Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Practice Point
  • Published:

Treatment of hypercholesterolemia in patients with the metabolic syndrome: how do various statins compare?

Nature Clinical Practice Cardiovascular Medicine volume 3, pages 134–135 (2006)Cite this article

boxed-textStender S et al. (2005) Comparison of rosuvastatin with atorvastatin, simvastatin and pravastatin in achieving cholesterol goals and improving plasma lipids in hypercholesterolaemic patients with or without the metabolic syndrome in the MERCURY I trial. Diabetes Obes Metab 7: 430–438

Background

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

References

  1. Grundy SM et al. (2004) Implications of recent clinical trials for the National Cholesterol Education Program Adult Treatment Panel III guidelines. Circulation 110: 227–239

    Article  Google Scholar 

  2. Ray KK et al. (2005) Early and late benefits of high-dose atorvastatin in patients with acute coronary syndromes: results from the PROVE IT-TIMI 22 trial. J Am Coll Cardiol 46: 1405–1410

    Article  CAS  Google Scholar 

  3. de Lemos JA et al. (2004) Early intensive vs a delayed conservative simvastatin strategy in patients with acute coronary syndromes: phase Z of the A to Z Trial. JAMA 292: 1307–1316

    Article  CAS  Google Scholar 

  4. Pyörälä K et al. (2004) Reduction in cardiovascular events by simvastatin in non-diabetic coronary heart disease patients with and without the metabolic syndrome: subgroup analyses of the Scandinavian Simvastatin Survival Study. Diabetes Care 27: 1735–1740

    Article  Google Scholar 

  5. Schwartz GG et al. (2005) Relation of characteristics of metabolic syndrome to short-term prognosis and effects of intensive statin therapy after acute coronary syndrome: an analysis of the myocardial ischemia reduction with aggressive cholesterol lowering (MIRACL) trial. Diabetes Care 28: 2508–2513

    Article  Google Scholar 

Download references

Acknowledgements

The synopsis was written by Hannah Camm, Associate Editor, Nature Clinical Practice.

Author information

Authors and Affiliations

  1. Lipid Research Clinic at Baylor College of Medicine, Houston, TX, USA

    William Insull Jr

Authors
  1. William Insull Jr
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to William Insull Jr.

Ethics declarations

Competing interests

The author declares no competing financial interests.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Insull, W. Treatment of hypercholesterolemia in patients with the metabolic syndrome: how do various statins compare?. Nat Rev Cardiol 3, 134–135 (2006). https://doi.org/10.1038/ncpcardio0483

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1038/ncpcardio0483

Search

Advanced search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing